Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Uman Pharma

Explore full profile

Uman Pharma | Generic injectable pharmaceutical products in Canada

Candiac, CanadaFounded 2008Biotech & Life Sciences
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Uman Pharma and the history behind them.

About Uman Pharma

Pharmascience International, a division of Pharmascience Inc., is a full-service pharmaceutical company with strong roots in Canada and a growing global presence. Founded in 1983, the company has over 35 years of experience in the pharmaceutical industry, serving patients and healthcare providers. Pharmascience International specializes in the development, manufacturing, and marketing of prescription generic drugs, over-the-counter (OTC) products, and FDA-approved injectables. The company operates in more than 60 countries, with offices located in Montreal, Europe, Cyprus, Saudi Arabia, South Korea, Vietnam, and Ukraine.

Pharmascience International serves a diverse range of clients, including hospitals, pharmacies, and healthcare providers. The company operates in the highly competitive pharmaceutical market, focusing on providing high-quality, cost-effective medications. Its business model revolves around the development and commercialization of generic drugs, which are bioequivalent to brand-name drugs but are sold at a lower price. This approach allows Pharmascience International to capture market share by offering affordable alternatives to expensive brand-name medications.

Revenue is generated through the sale of its pharmaceutical products, both domestically and internationally. The company leverages its extensive manufacturing capabilities and regulatory expertise to ensure compliance with international standards, thereby facilitating market entry and expansion.

Source: Dealroom company data

At a glance

Founded
2008
Headquarters
Candiac, Canada
Sector
Biotech & Life Sciences

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • CFR Pharmaceuticals
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇦 Canada · Candiac HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Uman Pharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Uman Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.